|
BCLI Brainstorm Cell Therapeutics Inc 1137883 |
| Income Statement |
|
Net Income
|
2026-06-30
|
$-3,855,000.00 |
| Balance Sheet |
|
Current Assets
|
$316,000.00 |
|
Assets
|
$788,000.00 |
|
Current Liabilities
|
$12,385,000.00 |
|
Liabilities
|
$12,385,000.00 |
|
Equity
|
$-11,597,000.00 |
|
Shares Out
|
11034775.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-895,000.00 |
|
Investing Cash Flow
|
$12,000.00 |
| Market Analysis |
Market Cap
|
$11,696,861.50 |
|
Price
|
$1.06 |
|
PB
|
1.38 |
|
EPS
|
-0.35 |
|
FCF
|
$-913,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:33:01 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:51 |
|
| Apr |
May |
Jun |
| 2026-03-31 |
-1.11 |
|
|
|
|
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-14 |
-0.34 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-14 |
-0.19 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view BCLI documents filed with the SEC.
BCLI Filings
Clear
